Protective effects of caffeic acid on lactate dehydrogenase isoenzymes, electrocardiogram, adenosine triphosphatases, and hematology on isoproterenol-induced myocardial infarcted rats

Journal of Biochemical and Molecular Toxicology

Volumn 25, Issue 2, 2011, Pages 60-67

  Senthil Kumaran, K ^a   Stanely Mainzen Prince, P ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Caffeic Acid; Electrocardiogram; Isoproterenol; Membrane Bound ATPases; Myocardial Infarction

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CAFFEIC ACID; HEMOGLOBIN; ISOPRENALINE; LACTATE DEHYDROGENASE ISOENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL PARAMETERS; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; ENZYME ACTIVITY; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; HEART INFARCTION; HEMATOLOGY; HEMOGLOBIN BLOOD LEVEL; IN VITRO STUDY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; NEUTROPHIL COUNT; NONHUMAN; RAT; ST SEGMENT ELEVATION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CAFFEIC ACIDS; DRUG EVALUATION, PRECLINICAL; ELECTROCARDIOGRAPHY; FREE RADICAL SCAVENGERS; HEMATOLOGY; ISOENZYMES; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MALE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 79953688236     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20359     Document Type: Article

References (39)

1. Gilski DJ, Borkenhagen B. Risk evaluation for cardiovascular health. Crit Care Nurse 2005;25:26-28.
2. Anversa P, Sonnenblick EH. Ischemic cardiomyopathy: pathophysiologic mechanisms. Prog Cardiovasc Dis 1990;33:49-70.
3. Chagoya de Sanchez V, Hernandez-Munoz R, Lopez-Barrera F, Yanez L, Vidrio S, Suarez J, Cota-Garza MD, Aranda-Fraustro A, Cruz D. Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Can J Physiol Pharmacol 1997;75:1300-1311.
4. Ithayarasi AP, Devi CS. Effect of alpha-tocopherol on lipid peroxidation in isoproterenol induced myocardial infarction in rats. Ind J Physiol Pharmacol 1997;41:369-376.
5. Kukreja RC, Hess ML. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res 1992;26:641-655.
6. Voet JG, Donald V. ATP driven active transport. In: Textbook of Biochemistry, 2nd edition. New York: Wiley; 1995. pp 524-535.
7. Prabhu S, Shyamala Devi CS. Protective effect of mangiferin, an active phytochemical and cardiotonic from Mangifera indica Linn on isoproterenol induced myocardial infarcted rats: an electrocardiographic, electrophoretic and biochemical evidences. Pharmacogn Mag 2006;2:183-190.
8. Sampath PD, Vijayaragavan K. Ameliorative prospective of alpha- mangostin, a xanthone derivative from Garcinia mangostana against β-adrenergic cathecolamine-induced myocardial toxicity and anomalous cardiac TNF-α and COX-2 expressions in rats. Exp Toxicol Pathol 2008;60:357-364.
9. Prabhu S, Jainu M, Sabitha KE, Shyamala Devi CS. A study on the beneficial effect of mangiferin on isoproterenol induced myocardial infarction rat model. Pharmacogn Mag 2005;1:92-96.
10. Gordana S, Cetkovic, Jasna M, Canadanovic-Brunet, Sonja M, Djilas, Vesna T, Tumbas, Sinisa L, Markov Dragoljub D, Cvetkovic. Antioxidant potential, lipid peroxidation inhibition and antimicrobial activities of Satureja montana L. subsp. kitaibelii extracts. Int J Mol Sci 2007;8:1013-1027.
11. Kuhnau J. The flavonoids, a class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976;24:117-191.
12. Mattila P, Kumpulainen J. Determination of free and total phenolic acids in plant-derived foods by high performance liquid chromatography with diode-array detection. J Agric Food Chem 2002;50:3660-3667.
13. Bryngelsson S, Dimberg LH, Kamal-Eldin A. Effects of commercial processing on levels of antioxidants in oats (Avena sativa L). J Agric Food Chem 2002;50:1890-1896.
14. Castellari M, Sartini E, Fabiani A, Arfelli G, Amati A. Analysis of wine phenolics by high-performance liquid chromatography using a monolithic type column. J Chromatogr A 2002;973:221-227.
15. National Research Council. Carcinogens and anticarcinogens in the human diet. Washington, DC: National Academy Press; 1996. pp 2931-2937.
16. Kono Y, Kobayashi K, Tagawa S, Adachi K, Ueda A, Sawa Y, Shibata H. Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen. Biochim Biophys Acta 1997;1335:335-342.
17. Gulcin I. Antioxidant activity of caffeic acid (3, 4-dihydroxy cinnamic acid). Toxicology 2006;217:213-220.
18. Nardini M, D'Aquino M, Tomassi G, Gentili V, Di-Felice M, Scaccini C. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxy cinnamic acid derivatives. Free Radic Biol Med 1995;19:541-552.
19. Psotova J, Lasovsky J, Vicar J. Metal-chelating properties, electrochemical behavior, scavenging and cytoprotective activities of six natural phenolics. Biomed 2003;147:147-153.
20. Karthikeyan K, Sarala Bai BR, Niranjali Devaraj S. Grape seed proanthocyanidins ameliorates isoproterenol-induced myocardial injury in rats by stabilizing mitochondrial and lysosomal enzymes: an in vivo study. Life Sci 2007;81:1615-1621.
21. Senthil Kumaran K, Stanely Mainzen Prince P. Preventive effect of caffeic acid on lysosomal dysfunction in isoproterenol- induced myocardial infarcted rats. J Biochem Mol Toxicol (in press).
22. Senthil Kumaran K, Stanely Mainzen Prince P. Protective effect of caffeic acid on cardiac markers and lipid peroxide metabolism in cardiotoxic rats: an in vivo and in vitro study. Metabol Clin Exp (in press).
23. McKenzie D, Henderson AR. Electrophoresis of lactate dehydrogenase isoenzymes. Clin Chem 1983;29:189-195.
24. Bonting SL. Membrane and ion transport. In: Bittar EE, editor. Presence of enzyme systems in mammalian tissues. London: Wiley Interscience; 1970. Vol 1, pp 257-263.
25. 2+-ATPase activities in normal, regenerating and malignant cells. Biochim Biophys Acta 1982;684:67-74.
26. 2+-ATPase from erythrocyte membranes. Biochim Biophys Acta 1983;728:281-288.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin's phenol reagent. J Biol Chem 1951;193:265-275.
28. Bottiger LE, Svedberg CA. Normal erythrocyte sedimentation rate and age. Br Med J 1967;2:85-87.
29. Mensor LL, Menezes FS, Leitao GG, Reis AS, Dos Santos TC, Coube CS, Leitao SG. Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method. Phytother Res 2001;15:127-130.
30. Jaffe AS, Landt Y, Parvin CA, Abendschein DR, Geltman EM, Ladenson JH. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction. Clin Chem 1996;42:1770-1776.
31. Wang SB, Tian S, Yang F, Yang HG, Yang XY, Du GH. Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats. Eur J Pharmacol 2009;615:125-132.
32. Holland RP, Brooks H. TQ-ST segment mapping: critical review and analysis of current concepts. Am J Cardiol 1977;40:110-129.
33. 4 induced liver cirrhosis. Protection by silymarin. Life Sci 1991;48:1083-1090.
34. Trump BF, Berezesky IK, Sato T, Laiho KU, Phelps PC, DeClaris N. Cell calcium, cell injury and cell death. Environ Health Perspect 1984;57:281-287.
35. Hamet P. The evaluation of the scientific evidence for a relationship between calcium and hypertension. J Nutr 1995;125:S311-S400.
36. Ernst E, Weihmayr T, Schmid M, Baumann M, Matrai A. Cardiovascular risk factors and hemorheology. Physical fitness, stress and obesity. Atherosclerosis 1986;59:263-269.
37. Burr ML, Holliday RM, Fehily AM, Whitehead PJ. Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). Eur Heart J 1992;13:166-170.
38. Friedman GD, Tekawa I, Grimm RH, Manolio T, Shannon SG, Sidney S. The leucocyte count: correlates and relationship to coronary risk factors: The CARDIA study. Int J Epidemiol 1990;19:889-893.
39. Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 1998;97:19-22.